Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea flag South Korea · Delayed Price · Currency is KRW
18,230
-1,470 (-7.46%)
Last updated: Jun 8, 2026, 1:38 PM KST

Ildong Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
620,7091,213,061328,764502,483764,721799,187
Market Cap Growth
92.23%268.98%-34.57%-34.29%-4.31%77.78%
Enterprise Value
698,3841,310,725467,886480,579872,139869,595
Last Close Price
19700.0038245.4511692.1818039.9328361.2433377.85
PE Ratio
17.3243.85----
Forward PE
-14.7614.7614.7614.7614.76
PS Ratio
1.082.140.540.841.201.43
PB Ratio
2.474.941.982.803.754.79
P/TBV Ratio
2.755.422.483.754.967.37
P/FCF Ratio
165.23228.7018.67---
P/OCF Ratio
35.8264.0111.62---
PEG Ratio
-0.860.860.860.860.86
EV/Sales Ratio
1.222.310.760.801.371.55
EV/EBITDA Ratio
15.4532.8512.52---
EV/EBIT Ratio
30.4375.6740.93---
EV/FCF Ratio
185.91247.1226.56---
Debt / Equity Ratio
0.530.591.241.191.021.36
Debt / EBITDA Ratio
2.983.625.50---
Debt / FCF Ratio
35.5827.2311.67---
Net Debt / Equity Ratio
0.300.320.730.730.630.43
Net Debt / EBITDA Ratio
1.661.993.23-5.24-2.92-2.85
Net Debt / FCF Ratio
19.8514.986.85-2.64-1.97-2.75
Asset Turnover
1.010.981.020.950.940.85
Inventory Turnover
3.493.694.424.234.443.97
Quick Ratio
0.530.510.520.410.440.59
Current Ratio
1.040.990.920.690.910.84
Return on Equity (ROE)
14.65%11.51%-7.17%-42.25%-76.68%-47.91%
Return on Assets (ROA)
2.48%1.86%1.19%-5.27%-6.75%-5.17%
Return on Invested Capital (ROIC)
5.33%4.23%3.82%-16.60%-25.79%-18.97%
Return on Capital Employed (ROCE)
6.50%5.00%3.60%-19.80%-21.30%-15.50%
Earnings Yield
5.62%2.28%-1.39%-15.71%-18.52%-12.48%
FCF Yield
0.61%0.44%5.36%-9.91%-8.55%-3.25%
Dividend Yield
1.02%0.52%----
Payout Ratio
0.17%0.22%----
Buyback Yield / Dilution
-13.56%-10.01%-3.34%-2.61%-10.76%0.00%
Total Shareholder Return
-12.55%-9.49%-3.34%-2.61%-10.76%0.00%